Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Influence of pharmaceutical intervention on patients at cardiovascular risk
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: CPS-033
- By: DE LA MATTA MARTíN, María (Officila College Of Pharmacist Of Sevilla, Spain, Spain)
- Co-author(s): Dr María De La Matta Martín, Member Of The Health Care Pharmacy Departmentrtment (Officila College Of Pharmacist Of Sevilla, Spain, Sevilla, Spain)
Prof María Martín Calero, Pharmacology
Prof Rocío de la Puerta Vázquez, Pharmacology
Pharmacist Pilar Buenavida Jurado
Background Information. Cardiovascular disease (CVD) is the leading cause of death in the world. Despite this, many people with CV risk factors (CVRF) who are at risk for these diseases often do not achieve the desired therapeutic goals with their treatments.
Purpose. To evaluate the effectiveness of a complex intervention based on.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019